GENE ONLINE|News &
May 11, 2012: Global ELSI 2.0 Launched Officially
ELSI 2.0 (Ethical, Legal, and Social Implications 2.0) is a genomic platform launched as a collaborative concept in Science journal (Vol. 336 no. 6082 pp. 673-674) on May 11, 2012. The aim of ELSI 2.0 is to catalyze an international collaboratory to solve ethical, legal, and scientific challenges in the field of genomics. With members from all over the world, ELSI 2.0 is operated to make the existing ELSI research more effective, efficient, and economical.
Reference
http://www.p3g.org/programmes/elsi-20
http://science.sciencemag.org/content/336/6082/673
Author
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
